ESMO 2023: Erdafitinib Improves Overall Survival in Patients With Metastatic Urothelial Carcinoma
Results of THOR cohort 1 trial confirm effects on patients with FGFR alterations
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.